ArticleFrontiers in neuroscience2025

REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID.

Suzanne D Vernon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.